Interações de Metiltestosterona

These drugs include, but are not limited to, the following: the anticonvulsants carbamazepine, oxcarbazepine, phenobarbital, phenytoin the androgen receptor inhibitor enzalutamide the antimycobacterials rifampin, rifapentine the cytotoxic agent mitotane St. (bula de Doravirina, Contraindicações)

Because of the ability of Type II 5α-reductase inhibitors to inhibit the conversion of testosterone to 5α-dihydrotestosterone (DHT), finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant female who receives finasteride. (bula de Finasterida, Contraindicações)

CONTRAINDICATIONS: Precocious puberty, prostatic carcinoma or other androgen-dependent neoplasm, prior allergic reaction to HCG. (bula de Gonadotrofina coriônica, Contraindicações)

To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk of major adverse cardiovascular events (MACE), such as non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, with the use of testosterone compared to non-use. (bula de Metiltestosterona, Advertências)

PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (bula de Alfacoriogonadotropina, Precauções)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Abiraterone: Spironolactone binds to the androgen receptor and may increase prostate‑specific antigen (PSA) levels in abiraterone-treated prostate cancer patients. (bula de Espironolactona + hidroclorotiazida, Interações medicamentosas)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (bula de Estradiol + noretisterona, Advertências e precauções)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (bula de Estrogênios conjugados, Precauções)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (bula de Estrogênios conjugados + bazedoxifeno, Advertências e precauções)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

For Men : Clinical monitoring for spermatogenesis utilizes the following indirect or direct measures: Serum testosterone level Semen analysis 5.11 FOLLISTIM Pen The FOLLISTIM Pen is intended only for use with FOLLISTIM AQ Cartridge. (bula de Folitropina, Advertências e precauções)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

…medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H 2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (bula de Glimepirida, Interações medicamentosas)

Effect on QT/QTc Interval: Androgen deprivation therapy may prolong the QT interval. (bula de Gosserrelina, Advertências e precauções)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Tumor Flare: Increased serum testosterone (~ 50% above baseline) may occur when initiating treatment with LUPRON DEPOT. (bula de Leuprorrelina, Advertências e precauções)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nictonic Acid These drugs may decrease serum TBG concentration. (bula de Levotiroxina, Interações medicamentosas)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nicotinic Acid These drugs may decrease serum TBG concentration. (bula de Liotironina, Interações medicamentosas)

However, clinical studies have shown that lovastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve, and does not reduce basal plasma testosterone concentration. (bula de Lovastatina, Interações medicamentosas)

The following laboratory tests may be affected by progestins including MPA Injectable Suspension, USP: (a) Plasma and urinary steroid levels are decreased (e.g., progesterone, estradiol, pregnanediol, testosterone, cortisol). (bula de Medroxiprogesterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

…anti-diabetic medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (bula de Pioglitazona + glimepirida, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Reproductive effects: Include decreased testosterone and increased prolactin levels. (bula de Ramelteona, Advertências e precauções)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

Hypercalcemia in Patients with Metastatic Breast Cancer As with other additive hormonal therapy (estrogens and androgens), hypercalcemia has been reported in some breast cancer patients with bone metastases within a few weeks of starting treatment with tamoxifen. (bula de Tamoxifeno, Advertências e precauções)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (bula de Metiltestosterona, Interações medicamentosas)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (bula de Metiltestosterona, Advertências)

Tumor Flare: Transient increase in serum testosterone levels can occur within the first few weeks of treatment. (bula de Triptorrelina, Advertências e precauções)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (bula de Metiltestosterona, Interações medicamentosas)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (bula de Metiltestosterona, Precauções)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (bula de Metiltestosterona, Precauções)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (bula de Metiltestosterona, Precauções)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (bula de Metiltestosterona, Precauções)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)

In addition to discontinuation of the drug, diuretic therapy may be required. (bula de Metiltestosterona, Advertências)